The U.S. Food and Drug Administration (FDA) Nanotechnology Task Force is celebrating NanoDay on October 9, 2020, by hosting a virtual research symposium to showcase more than a decade of progress and innovation in nanotechnology at FDA. The agenda lists the following presentations:
- A Decade of Progress and Innovation in Nanotechnology at U.S. FDA;
- Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology;
- Regulatory Science Research in Nanotechnology;
- Drug Products That Contain Nanomaterials;
- Nanotechnology and Medical Devices: A Regulatory Science Approach Involving Research, Standards, and Risk Assessment;
- Food Ingredients and Food Contact Substances Containing Nanomaterials: Guidance for Manufacturing Process Change;
- Use of Nanomaterials in Foods and Drugs for Animals;
- Virtual Tour of the Nanocore Facilities (five-minute video);
- Biological Products That Contain Nanomaterials;
- Office of Regulatory Affairs (ORA) and Nanomaterials;
- Safety of Nanomaterials in Cosmetic Products;
- Liposome Drug Products Guidance;
- Standards in Nanotechnology;
- Collaborative Opportunities for Research Excellence in Science (CORES) Intramural Grants Program; and
- Highlights of Nanotechnology Research at FDA.
Registration is now open.
[View source.]
